Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Intralesional Triamcinolone Therapy for Pretibial Myxedema
Pearon G. Lang
, James C. Sisson
, Peter J. Lynch
Dermatology
Research output
:
Contribution to journal
›
Article
›
peer-review
38
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intralesional Triamcinolone Therapy for Pretibial Myxedema'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Triamcinolone Acetonide
100%
Dosage Schedule
100%
Pretibial Myxedema
100%
Treatment Programs
50%
Triamcinolone
50%
Plaque
50%
Nodule
50%
Complete Resolution
50%
Effective Dose
50%
Completion of Therapy
50%
Intralesional Injection
50%
Reinjection
50%
Myxedema
50%
New Nodules
50%
Biochemistry, Genetics and Molecular Biology
Drug Dose Regimen
100%
Triamcinolone
100%
Solution and Solubility
50%
Triamcinolone Acetonide
50%
Prospective Study
50%
Immunology and Microbiology
Triamcinolone
100%
Drug Dose Regimen
66%
Solution and Solubility
33%